stockportfolio.pro
Stocks / CVS vs PFE
CVS vs PFE
CVS Health Corporation and Pfizer Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| CVS Health Corporation (CVS) | Pfizer Inc. (PFE) | |
|---|---|---|
| Market cap | $123.8B | $146.5B |
| Revenue (latest FY) | $402.07B | $62.58B |
| Net income (latest FY) | $1.77B | $7.77B |
| Revenue growth (5y CAGR) | 8.4% | 8.5% |
| Net margin | 0.4% | 12.4% |
| Return on equity | 2.4% | 9.0% |
| P/E ratio | 42.6 | 19.6 |
| Dividend yield | 2.7% | 6.7% |
| Profitable years (of last 10) | 9 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CVS — free Open PFE — freeFrequently asked questions
Which is bigger, CVS or PFE?
Pfizer Inc. is larger by market capitalization — $146.5B versus $123.8B.
Which grows faster, CVS or PFE?
Over the last five fiscal years, Pfizer Inc. grew revenue faster — 8.5%/yr versus 8.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.